Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis

Mult Scler. 2010 Dec;16(12):1529-30; author reply 1531-2. doi: 10.1177/1352458510382248. Epub 2010 Sep 9.
No abstract available

Publication types

  • Comment
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Neutralizing / blood*
  • Antibodies, Neutralizing / immunology
  • Azathioprine / therapeutic use*
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Interferon-beta / immunology
  • Interferon-beta / therapeutic use*
  • Methylprednisolone / therapeutic use*
  • Multiple Sclerosis, Relapsing-Remitting / blood
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy
  • Multiple Sclerosis, Relapsing-Remitting / immunology*

Substances

  • Antibodies, Neutralizing
  • Immunosuppressive Agents
  • Interferon-beta
  • Azathioprine
  • Methylprednisolone